• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CFLAR:一种软组织肉瘤中新型的诊断和预后生物标志物,它能正向调节肿瘤微环境中的免疫反应。

CFLAR: A novel diagnostic and prognostic biomarker in soft tissue sarcoma, which positively modulates the immune response in the tumor microenvironment.

作者信息

Liu Xu, Li Xiaoyang, Yu Shengji

机构信息

Department of Orthopedics, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China.

出版信息

Oncol Lett. 2024 Feb 14;27(4):151. doi: 10.3892/ol.2024.14284. eCollection 2024 Apr.

DOI:10.3892/ol.2024.14284
PMID:38406597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10885000/
Abstract

Anoikis is highly associated with tumor cell apoptosis and tumor prognosis; however, the specific role of anoikis-related genes (ARGs) in soft tissue sarcoma (STS) remains to be fully elucidated. The present study aimed to use a variety of bioinformatics methods to determine differentially expressed anoikis-related genes in STS and healthy tissues. Subsequently, three machine learning algorithms, Least Absolute Shrinkage and Selection Operator, Support Vector Machine and Random Forest, were used to screen genes with the highest importance score. The results of the bioinformatics analyses demonstrated that CASP8 and FADD-like apoptosis regulator (CFLAR) exhibited the highest importance score. Subsequently, the diagnostic and prognostic value of CFLAR in STS development was determined using multiple public and in-house cohorts. The results of the present study demonstrated that CFLAR may be considered a diagnostic and prognostic marker of STS, which acts as an independent prognostic factor of STS development. The present study also aimed to explore the potential role of CFLAR in the STS tumor microenvironment, and the results demonstrated that CFLAR significantly enhanced the immune response of STS, and exerted a positive effect on the infiltration of CD8 T cells and M1 macrophages in the STS immune microenvironment. Notably, the aforementioned results were verified using multiplex immunofluorescence analysis. Collectively, the results of the present study demonstrated that CFLAR may act as a novel diagnostic and prognostic marker for STS, and may positively regulate the immune response of STS. Thus, the present study provided a novel theoretical basis for the use of CFLAR in STS diagnosis, in predicting clinical outcomes and in tailoring individualized treatment options.

摘要

失巢凋亡与肿瘤细胞凋亡及肿瘤预后高度相关;然而,失巢凋亡相关基因(ARGs)在软组织肉瘤(STS)中的具体作用仍有待充分阐明。本研究旨在运用多种生物信息学方法,确定STS组织和健康组织中差异表达的失巢凋亡相关基因。随后,使用三种机器学习算法,即最小绝对收缩和选择算子、支持向量机和随机森林,筛选出重要性得分最高的基因。生物信息学分析结果表明,含半胱氨酸的天冬氨酸蛋白水解酶8和FADD样凋亡调节因子(CFLAR)的重要性得分最高。随后,利用多个公共数据集和内部队列确定CFLAR在STS发生发展中的诊断和预后价值。本研究结果表明,CFLAR可被视为STS的诊断和预后标志物,它是STS发生发展的独立预后因素。本研究还旨在探讨CFLAR在STS肿瘤微环境中的潜在作用,结果表明CFLAR显著增强了STS的免疫反应,并对STS免疫微环境中CD8 T细胞和M1巨噬细胞的浸润发挥了积极作用。值得注意的是,上述结果通过多重免疫荧光分析得到了验证。总体而言,本研究结果表明,CFLAR可能作为STS的一种新型诊断和预后标志物,并可能对STS的免疫反应起到正向调节作用。因此,本研究为CFLAR在STS诊断、预测临床结果及制定个体化治疗方案中的应用提供了新的理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/10885000/bf460b6ce92b/ol-27-04-14284-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/10885000/2e6d71b9d769/ol-27-04-14284-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/10885000/c2ec2b384d01/ol-27-04-14284-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/10885000/cd3813b2f3ae/ol-27-04-14284-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/10885000/7fec1c8bf79e/ol-27-04-14284-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/10885000/fa803f030eff/ol-27-04-14284-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/10885000/e641021f9cfe/ol-27-04-14284-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/10885000/bf460b6ce92b/ol-27-04-14284-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/10885000/2e6d71b9d769/ol-27-04-14284-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/10885000/c2ec2b384d01/ol-27-04-14284-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/10885000/cd3813b2f3ae/ol-27-04-14284-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/10885000/7fec1c8bf79e/ol-27-04-14284-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/10885000/fa803f030eff/ol-27-04-14284-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/10885000/e641021f9cfe/ol-27-04-14284-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/10885000/bf460b6ce92b/ol-27-04-14284-g06.jpg

相似文献

1
CFLAR: A novel diagnostic and prognostic biomarker in soft tissue sarcoma, which positively modulates the immune response in the tumor microenvironment.CFLAR:一种软组织肉瘤中新型的诊断和预后生物标志物,它能正向调节肿瘤微环境中的免疫反应。
Oncol Lett. 2024 Feb 14;27(4):151. doi: 10.3892/ol.2024.14284. eCollection 2024 Apr.
2
Integrative profiling analysis reveals prognostic significance, molecular characteristics, and tumor immunity of angiogenesis-related genes in soft tissue sarcoma.整合分析揭示了软组织肉瘤中血管生成相关基因的预后意义、分子特征和肿瘤免疫。
Front Immunol. 2023 Jun 12;14:1178436. doi: 10.3389/fimmu.2023.1178436. eCollection 2023.
3
Identification of anoikis-related molecular patterns to define tumor microenvironment and predict immunotherapy response and prognosis in soft-tissue sarcoma.鉴定与失巢凋亡相关的分子模式以定义肿瘤微环境并预测软组织肉瘤的免疫治疗反应和预后
Front Pharmacol. 2023 Mar 1;14:1136184. doi: 10.3389/fphar.2023.1136184. eCollection 2023.
4
Integration analysis based on fatty acid metabolism robustly predicts prognosis, dissecting immunity microenvironment and aiding immunotherapy for soft tissue sarcoma.基于脂肪酸代谢的整合分析能有力地预测软组织肉瘤的预后、剖析免疫微环境并辅助免疫治疗。
Front Genet. 2023 Mar 30;14:1161791. doi: 10.3389/fgene.2023.1161791. eCollection 2023.
5
Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma.多种 RNA 修饰调控因子的串扰揭示了软组织肉瘤中的肿瘤微环境和免疫浸润。
Front Immunol. 2022 Jul 4;13:921223. doi: 10.3389/fimmu.2022.921223. eCollection 2022.
6
A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer.一种新的与失巢凋亡相关的基因预后特征及其与结直肠癌免疫微环境的相关性。
Front Genet. 2023 May 30;14:1186862. doi: 10.3389/fgene.2023.1186862. eCollection 2023.
7
Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.鉴定和验证与透明细胞肾细胞癌预后相关的新型凋亡相关基因特征。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11661-11678. doi: 10.1007/s00432-023-05012-6. Epub 2023 Jul 5.
8
A Combined Risk Score Model to Assess Prognostic Value in Patients with Soft Tissue Sarcomas.软组织肉瘤患者预后评估的联合风险评分模型。
Cells. 2022 Dec 16;11(24):4077. doi: 10.3390/cells11244077.
9
Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma.建立并验证一种新型的与细胞黏附丧失相关的肾透明细胞癌预后标志物。
Front Immunol. 2023 Mar 28;14:1171883. doi: 10.3389/fimmu.2023.1171883. eCollection 2023.
10
Identification of A novel anoikis-related genes-based signature for non-small cell lung cancer.鉴定一种新型非小细胞肺癌相关的失巢凋亡基因标志物。
Biochem Biophys Res Commun. 2023 Sep 17;673:137-144. doi: 10.1016/j.bbrc.2023.06.049. Epub 2023 Jun 16.

引用本文的文献

1
Potential role of CFLAR in enhancing 5-FU sensitivity and modulating immune cell infiltration in breast cancer.CFLAR在增强乳腺癌对5-氟尿嘧啶的敏感性及调节免疫细胞浸润中的潜在作用
Eur J Med Res. 2025 Apr 10;30(1):265. doi: 10.1186/s40001-025-02532-4.
2
Development and external validation of a machine learning-based model to predict postoperative recurrence in patients with duodenal adenocarcinoma: a multicenter, retrospective cohort study.基于机器学习的十二指肠腺癌患者术后复发预测模型的开发与外部验证:一项多中心回顾性队列研究
BMC Med. 2025 Feb 21;23(1):98. doi: 10.1186/s12916-025-03912-7.
3
Development and validation of a machine learning-based model to predict postoperative overall survival in patients with soft tissue sarcoma: a retrospective cohort study.

本文引用的文献

1
Elastic Net Regularization Paths for All Generalized Linear Models.所有广义线性模型的弹性网络正则化路径
J Stat Softw. 2023;106. doi: 10.18637/jss.v106.i01. Epub 2023 Mar 23.
2
Identification of Anoikis-Related Subgroups and Prognosis Model in Liver Hepatocellular Carcinoma.识别肝癌中的凋亡相关亚群和预后模型。
Int J Mol Sci. 2023 Feb 2;24(3):2862. doi: 10.3390/ijms24032862.
3
Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma.失巢凋亡模式在骨肉瘤中呈现出不同的预后和免疫格局。
基于机器学习的软组织肉瘤患者术后总生存预测模型的开发与验证:一项回顾性队列研究
Am J Cancer Res. 2024 Oct 15;14(10):4731-4746. doi: 10.62347/ZQVY3877. eCollection 2024.
Int Immunopharmacol. 2023 Feb;115:109684. doi: 10.1016/j.intimp.2023.109684. Epub 2023 Jan 9.
4
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis.cFLIP抑制和DR5激活使衰老癌细胞对衰老细胞溶解敏感。
Nat Cancer. 2022 Nov;3(11):1284-1299. doi: 10.1038/s43018-022-00462-2. Epub 2022 Nov 22.
5
CellMarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data.CellMarker 2.0:一个更新的数据库,包含基于 scRNA-seq 数据的人类/小鼠细胞标志物的人工注释和网络工具。
Nucleic Acids Res. 2023 Jan 6;51(D1):D870-D876. doi: 10.1093/nar/gkac947.
6
Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis.了解在转移的不同阶段中,抗失巢凋亡的癌细胞的细胞存活机制。
Clin Exp Metastasis. 2022 Oct;39(5):715-726. doi: 10.1007/s10585-022-10172-9. Epub 2022 Jul 13.
7
CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells.环状 RNA CEMIP 通过增强前列腺癌细胞的保护性自噬促进失巢凋亡抵抗。
J Exp Clin Cancer Res. 2022 Jun 2;41(1):188. doi: 10.1186/s13046-022-02381-7.
8
Towards targeting of shared mechanisms of cancer metastasis and therapy resistance.针对癌症转移和治疗耐药的共同机制的靶向治疗。
Nat Rev Cancer. 2022 Mar;22(3):157-173. doi: 10.1038/s41568-021-00427-0. Epub 2022 Jan 10.
9
clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.clusterProfiler 4.0:用于解释组学数据的通用富集工具。
Innovation (Camb). 2021 Jul 1;2(3):100141. doi: 10.1016/j.xinn.2021.100141. eCollection 2021 Aug 28.
10
Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma.免疫和遗传机制在滑膜肉瘤中塑造致癌程序。
Nat Med. 2021 Feb;27(2):289-300. doi: 10.1038/s41591-020-01212-6. Epub 2021 Jan 25.